{"id":95366,"date":"2025-03-10T16:56:15","date_gmt":"2025-03-10T15:56:15","guid":{"rendered":"https:\/\/www.formycon.com\/?p=95366"},"modified":"2025-03-10T16:56:15","modified_gmt":"2025-03-10T15:56:15","slug":"formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk","status":"publish","type":"post","link":"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/","title":{"rendered":"Formycon CFO Enno Spillner interviewed by Andreas Schmidt from the SdK"},"content":{"rendered":"

[vc_row][vc_column column_width_use_pixel=”yes” align_horizontal=”align_center” gutter_size=”3″ font_family=”font-130579″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″ uncode_shortcode_id=”279312″ column_width_pixel=”800″][vc_custom_heading text_font=”font-126351″ text_transform=”uppercase” sub_lead=”small” uncode_shortcode_id=”209584″ subheading=”March 07, 2025″]<\/p>\n

Formycon CFO Enno Spillner interviewed by Andreas Schmidt from the SdK<\/h2>\n

[\/vc_custom_heading][\/vc_column][\/vc_row][vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”2″ top_padding=”2″ bottom_padding=”0″ overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ uncode_shortcode_id=”160712″][vc_column column_width_use_pixel=”yes” align_horizontal=”align_center” gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″ uncode_shortcode_id=”144889″ column_width_pixel=”800″ css=”.vc_custom_1729503584254{padding-bottom: -36px !important;}”][vc_column_text uncode_shortcode_id=”304013″]In a video interview with Andreas Schmidt from Schutzgemeinschaft der Kapitalanleger e.V. (SdK), Enno Spillner explains why Formycon can waive the phase III trial for the pembrolizumab biosimilar candidate FYB206. He also addresses the current dynamics on the US biosimilar market, which have led to reduced sales expectations for the ustekinumab biosimilar FYB202 and the temporary pause in the commercialization of the ranibizumab biosimilar FYB201 in the U.S.<\/p>\n

The interview is held in German.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”2″ top_padding=”2″ bottom_padding=”0″ overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ uncode_shortcode_id=”160712″][vc_column column_width_use_pixel=”yes” gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″ uncode_shortcode_id=”148088″ column_width_pixel=”800″ css=”.vc_custom_1729250724356{padding-bottom: -36px !important;}”][vc_raw_html]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[\/vc_raw_html][\/vc_column][\/vc_row][vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”2″ top_padding=”2″ bottom_padding=”0″ overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ uncode_shortcode_id=”160712″][vc_column column_width_use_pixel=”yes” align_horizontal=”align_center” gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″ uncode_shortcode_id=”180165″ column_width_pixel=”800″ css=”.vc_custom_1729504305950{padding-bottom: -36px !important;}”][vc_empty_space empty_h=”1″][vc_separator sep_color=”color-jevc” uncode_shortcode_id=”126413″ sep_color_type=”uncode-palette” el_height=”1px”][vc_empty_space empty_h=”1″][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column column_width_use_pixel=”yes” align_horizontal=”align_center” gutter_size=”3″ font_family=”font-130579″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″ uncode_shortcode_id=”279312″ column_width_pixel=”800″][vc_custom_heading text_font=”font-126351″ text_transform=”uppercase” sub_lead=”small” uncode_shortcode_id=”209584″ subheading=”March […]<\/p>\n","protected":false},"author":23,"featured_media":92392,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-95366","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nicht-kategorisiert"],"acf":[],"yoast_head":"\nFormycon CFO Enno Spillner interviewed by Andreas Schmidt from the SdK - FormyconAG \/\/ MedInfo<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Formycon CFO Enno Spillner interviewed by Andreas Schmidt from the SdK - FormyconAG \/\/ MedInfo\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column column_width_use_pixel=”yes” align_horizontal=”align_center” gutter_size=”3″ font_family=”font-130579″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″ uncode_shortcode_id=”279312″ column_width_pixel=”800″][vc_custom_heading text_font=”font-126351″ text_transform=”uppercase” sub_lead=”small” uncode_shortcode_id=”209584″ subheading=”March […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/\" \/>\n<meta property=\"og:site_name\" content=\"FormyconAG \/\/ MedInfo\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-10T15:56:15+00:00\" \/>\n<meta name=\"author\" content=\"Formycon AG\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TLadda\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Formycon AG\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/\",\"url\":\"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/\",\"name\":\"Formycon CFO Enno Spillner interviewed by Andreas Schmidt from the SdK - FormyconAG \/\/ MedInfo\",\"isPartOf\":{\"@id\":\"https:\/\/medinfo.formycon.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2025-03-10T15:56:15+00:00\",\"author\":{\"@id\":\"https:\/\/medinfo.formycon.com\/en\/#\/schema\/person\/f5283106426b73710bff714b74d044da\"},\"breadcrumb\":{\"@id\":\"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medinfo.formycon.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Formycon CFO Enno Spillner interviewed by Andreas Schmidt from the SdK\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medinfo.formycon.com\/en\/#website\",\"url\":\"https:\/\/medinfo.formycon.com\/en\/\",\"name\":\"FormyconAG \/\/ MedInfo\",\"description\":\"Informationen f\u00fcr Patienten und medizinisches Fachpersonal\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medinfo.formycon.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/medinfo.formycon.com\/en\/#\/schema\/person\/f5283106426b73710bff714b74d044da\",\"name\":\"Formycon AG\",\"sameAs\":[\"https:\/\/x.com\/TLadda\"],\"url\":\"https:\/\/medinfo.formycon.com\/en\/author\/tladda\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Formycon CFO Enno Spillner interviewed by Andreas Schmidt from the SdK - FormyconAG \/\/ MedInfo","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Formycon CFO Enno Spillner interviewed by Andreas Schmidt from the SdK - FormyconAG \/\/ MedInfo","og_description":"[vc_row][vc_column column_width_use_pixel=”yes” align_horizontal=”align_center” gutter_size=”3″ font_family=”font-130579″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″ uncode_shortcode_id=”279312″ column_width_pixel=”800″][vc_custom_heading text_font=”font-126351″ text_transform=”uppercase” sub_lead=”small” uncode_shortcode_id=”209584″ subheading=”March […]","og_url":"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/","og_site_name":"FormyconAG \/\/ MedInfo","article_published_time":"2025-03-10T15:56:15+00:00","author":"Formycon AG","twitter_card":"summary_large_image","twitter_creator":"@TLadda","twitter_misc":{"Written by":"Formycon AG","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/","url":"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/","name":"Formycon CFO Enno Spillner interviewed by Andreas Schmidt from the SdK - FormyconAG \/\/ MedInfo","isPartOf":{"@id":"https:\/\/medinfo.formycon.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/#primaryimage"},"image":{"@id":"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/#primaryimage"},"thumbnailUrl":"","datePublished":"2025-03-10T15:56:15+00:00","author":{"@id":"https:\/\/medinfo.formycon.com\/en\/#\/schema\/person\/f5283106426b73710bff714b74d044da"},"breadcrumb":{"@id":"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/medinfo.formycon.com\/en\/2025\/03\/10\/formycon-cfo-enno-spillner-interviewed-by-andreas-schmidt-from-the-sdk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medinfo.formycon.com\/en\/"},{"@type":"ListItem","position":2,"name":"Formycon CFO Enno Spillner interviewed by Andreas Schmidt from the SdK"}]},{"@type":"WebSite","@id":"https:\/\/medinfo.formycon.com\/en\/#website","url":"https:\/\/medinfo.formycon.com\/en\/","name":"FormyconAG \/\/ MedInfo","description":"Informationen f\u00fcr Patienten und medizinisches Fachpersonal","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medinfo.formycon.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/medinfo.formycon.com\/en\/#\/schema\/person\/f5283106426b73710bff714b74d044da","name":"Formycon AG","sameAs":["https:\/\/x.com\/TLadda"],"url":"https:\/\/medinfo.formycon.com\/en\/author\/tladda\/"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-24 19:14:10","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/medinfo.formycon.com\/en\/wp-json\/wp\/v2\/posts\/95366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medinfo.formycon.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medinfo.formycon.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medinfo.formycon.com\/en\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/medinfo.formycon.com\/en\/wp-json\/wp\/v2\/comments?post=95366"}],"version-history":[{"count":0,"href":"https:\/\/medinfo.formycon.com\/en\/wp-json\/wp\/v2\/posts\/95366\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medinfo.formycon.com\/en\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/medinfo.formycon.com\/en\/wp-json\/wp\/v2\/media?parent=95366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medinfo.formycon.com\/en\/wp-json\/wp\/v2\/categories?post=95366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medinfo.formycon.com\/en\/wp-json\/wp\/v2\/tags?post=95366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}